REIT - Diversified
Compare Stocks
5 / 10Stock Comparison
AAT vs WELL vs EQR vs VTR vs NHI
Revenue, margins, valuation, and 5-year total return — side by side.
REIT - Healthcare Facilities
REIT - Residential
REIT - Healthcare Facilities
REIT - Healthcare Facilities
AAT vs WELL vs EQR vs VTR vs NHI — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | |||||
|---|---|---|---|---|---|
| Industry | REIT - Diversified | REIT - Healthcare Facilities | REIT - Residential | REIT - Healthcare Facilities | REIT - Healthcare Facilities |
| Market Cap | $1.30B | $149.25B | $24.68B | $41.15B | $3.64B |
| Revenue (TTM) | $436M | $11.63B | $3.12B | $6.13B | $403M |
| Net Income (TTM) | $71M | $1.43B | $954M | $260M | $148M |
| Gross Margin | 61.1% | 39.1% | 46.3% | -4.3% | 61.3% |
| Operating Margin | 33.5% | 4.4% | 28.5% | 13.4% | 48.5% |
| Forward P/E | 45.7x | 79.6x | 47.7x | 119.0x | 22.2x |
| Total Debt | $1.71B | $21.38B | $8.78B | $13.22B | $1.16B |
| Cash & Equiv. | $129M | $5.03B | $56M | $741M | $20M |
AAT vs WELL vs EQR vs VTR vs NHI — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| American Assets Tru… (AAT) | 100 | 80.4 | -19.6% |
| Welltower Inc. (WELL) | 100 | 423.6 | +323.6% |
| Equity Residential (EQR) | 100 | 108.2 | +8.2% |
| Ventas, Inc. (VTR) | 100 | 249.7 | +149.7% |
| National Health Inv… (NHI) | 100 | 135.6 | +35.6% |
Price return only. Dividends and distributions are not included.
Quick Verdict: AAT vs WELL vs EQR vs VTR vs NHI
Each card shows where this stock fits in a portfolio — not just who wins on paper.
AAT has the current edge in this matchup, primarily because of its strength in income & stability and valuation efficiency.
- Dividend streak 5 yrs, beta 0.64, yield 6.5%
- PEG 3.08 vs EQR's 9.36
- Lower P/E (45.7x vs 119.0x)
- 6.5% yield, 5-year raise streak, vs EQR's 4.1%
WELL is the #2 pick in this set and the best alternative if long-term compounding and sleep-well-at-night is your priority.
- 223.1% 10Y total return vs VTR's 65.0%
- Lower volatility, beta 0.13, Low D/E 49.5%, current ratio 5.34x
- Beta 0.13, yield 1.3%, current ratio 5.34x
- 35.8% FFO/revenue growth vs AAT's -4.7%
Among these 5 stocks, EQR doesn't own a clear edge in any measured category.
VTR is the clearest fit if your priority is growth exposure.
- Rev growth 18.5%, EPS growth 184.2%, 3Y rev CAGR 12.2%
- Beta 0.01 vs AAT's 0.64, lower leverage
NHI ranks third and is worth considering specifically for quality and efficiency.
- 36.8% margin vs VTR's 4.2%
- 5.4% ROA vs VTR's 1.0%, ROIC 5.6% vs 2.5%
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 35.8% FFO/revenue growth vs AAT's -4.7% | |
| Value | Lower P/E (45.7x vs 119.0x) | |
| Quality / Margins | 36.8% margin vs VTR's 4.2% | |
| Stability / Safety | Beta 0.01 vs AAT's 0.64, lower leverage | |
| Dividends | 6.5% yield, 5-year raise streak, vs EQR's 4.1% | |
| Momentum (1Y) | +42.7% vs EQR's -2.7% | |
| Efficiency (ROA) | 5.4% ROA vs VTR's 1.0%, ROIC 5.6% vs 2.5% |
AAT vs WELL vs EQR vs VTR vs NHI — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
AAT vs WELL vs EQR vs VTR vs NHI — Financial Metrics
Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
NHI leads in 2 of 6 categories
AAT leads 1 • WELL leads 1 • EQR leads 0 • VTR leads 0 • 2 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
NHI leads this category, winning 4 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
WELL is the larger business by revenue, generating $11.6B annually — 28.9x NHI's $403M. NHI is the more profitable business, keeping 36.8% of every revenue dollar as net income compared to VTR's 4.2%. On growth, WELL holds the edge at +40.3% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | |||||
|---|---|---|---|---|---|
| RevenueTrailing 12 months | $436M | $11.6B | $3.1B | $6.1B | $403M |
| EBITDAEarnings before interest/tax | $273M | $2.8B | $1.9B | $2.3B | $282M |
| Net IncomeAfter-tax profit | $71M | $1.4B | $954M | $260M | $148M |
| Free Cash FlowCash after capex | $95M | $2.5B | $1.3B | $1.4B | $226M |
| Gross MarginGross profit ÷ Revenue | +61.1% | +39.1% | +46.3% | -4.3% | +61.3% |
| Operating MarginEBIT ÷ Revenue | +33.5% | +4.4% | +28.5% | +13.4% | +48.5% |
| Net MarginNet income ÷ Revenue | +16.4% | +12.3% | +30.6% | +4.2% | +36.8% |
| FCF MarginFCF ÷ Revenue | +21.7% | +21.9% | +42.7% | +22.4% | +56.1% |
| Rev. Growth (YoY)Latest quarter vs prior year | -3.0% | +40.3% | +2.5% | +22.0% | +29.7% |
| EPS Growth (YoY)Latest quarter vs prior year | -65.4% | +22.5% | -64.2% | 0.0% | +10.8% |
Valuation Metrics
AAT leads this category, winning 5 of 7 comparable metrics.
Valuation Metrics
At 22.6x trailing earnings, EQR trades at a 86% valuation discount to VTR's 160.3x P/E. Adjusting for growth (PEG ratio), AAT offers better value at 1.54x vs EQR's 4.44x — a lower PEG means you pay less per unit of expected earnings growth.
| Metric | |||||
|---|---|---|---|---|---|
| Market CapShares × price | $1.3B | $149.2B | $24.7B | $41.1B | $3.6B |
| Enterprise ValueMkt cap + debt − cash | $2.9B | $165.6B | $33.4B | $53.6B | $4.8B |
| Trailing P/EPrice ÷ TTM EPS | 22.95x | 153.25x | 22.63x | 160.26x | 24.85x |
| Forward P/EPrice ÷ next-FY EPS est. | 45.74x | 79.65x | 47.69x | 119.03x | 22.17x |
| PEG RatioP/E ÷ EPS growth rate | 1.54x | — | 4.44x | — | — |
| EV / EBITDAEnterprise value multiple | 10.51x | 66.40x | 15.61x | 24.31x | 17.16x |
| Price / SalesMarket cap ÷ Revenue | 2.97x | 13.99x | 7.96x | 7.05x | 9.61x |
| Price / BookPrice ÷ Book value/share | 1.48x | 3.35x | 2.24x | 3.18x | 2.29x |
| Price / FCFMarket cap ÷ FCF | 13.66x | 52.41x | 19.13x | 31.25x | 16.52x |
Profitability & Efficiency
NHI leads this category, winning 6 of 9 comparable metrics.
Profitability & Efficiency
NHI delivers a 9.8% return on equity — every $100 of shareholder capital generates $10 in annual profit, vs $2 for VTR. WELL carries lower financial leverage with a 0.49x debt-to-equity ratio, signaling a more conservative balance sheet compared to AAT's 1.56x. On the Piotroski fundamental quality scale (0–9), WELL scores 7/9 vs AAT's 5/9, reflecting strong financial health.
| Metric | |||||
|---|---|---|---|---|---|
| ROE (TTM)Return on equity | +6.4% | +3.5% | +8.4% | +2.1% | +9.8% |
| ROA (TTM)Return on assets | +2.4% | +2.3% | +4.6% | +1.0% | +5.4% |
| ROICReturn on invested capital | +4.1% | +0.5% | +4.2% | +2.5% | +5.6% |
| ROCEReturn on capital employed | +4.9% | +0.6% | +5.7% | +3.2% | +8.0% |
| Piotroski ScoreFundamental quality 0–9 | 5 | 7 | 6 | 6 | 6 |
| Debt / EquityFinancial leverage | 1.56x | 0.49x | 0.77x | 1.05x | 0.76x |
| Net DebtTotal debt minus cash | $1.6B | $16.3B | $8.7B | $12.5B | $1.1B |
| Cash & Equiv.Liquid assets | $129M | $5.0B | $56M | $741M | $20M |
| Total DebtShort + long-term debt | $1.7B | $21.4B | $8.8B | $13.2B | $1.2B |
| Interest CoverageEBIT ÷ Interest expense | 1.92x | 0.26x | 5.58x | 1.40x | 3.45x |
Total Returns (Dividends Reinvested)
WELL leads this category, winning 6 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in WELL five years ago would be worth $30,234 today (with dividends reinvested), compared to $7,843 for AAT. Over the past 12 months, WELL leads with a +42.7% total return vs EQR's -2.7%. The 3-year compound annual growth rate (CAGR) favors WELL at 42.5% vs EQR's 5.5% — a key indicator of consistent wealth creation.
| Metric | |||||
|---|---|---|---|---|---|
| YTD ReturnYear-to-date | +14.2% | +14.3% | +8.4% | +12.6% | -1.1% |
| 1-Year ReturnPast 12 months | +18.1% | +42.7% | -2.7% | +33.9% | +2.8% |
| 3-Year ReturnCumulative with dividends | +33.2% | +189.5% | +17.5% | +94.2% | +73.5% |
| 5-Year ReturnCumulative with dividends | -21.6% | +202.3% | +6.7% | +74.8% | +31.0% |
| 10-Year ReturnCumulative with dividends | -21.9% | +223.1% | +29.3% | +65.0% | +58.9% |
| CAGR (3Y)Annualised 3-year return | +10.0% | +42.5% | +5.5% | +24.8% | +20.2% |
Risk & Volatility
Evenly matched — VTR and NHI each lead in 1 of 2 comparable metrics.
Risk & Volatility
NHI is the less volatile stock with a -0.08 beta — it tends to amplify market swings less than AAT's 0.64 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. VTR currently trades 97.8% from its 52-week high vs NHI's 82.5% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | |||||
|---|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 0.64x | 0.15x | 0.37x | -0.01x | -0.09x |
| 52-Week HighHighest price in past year | $21.61 | $219.59 | $71.80 | $88.50 | $90.94 |
| 52-Week LowLowest price in past year | $17.72 | $142.65 | $57.58 | $61.76 | $68.80 |
| % of 52W HighCurrent price vs 52-week peak | +97.7% | +97.0% | +91.7% | +97.8% | +82.5% |
| RSI (14)Momentum oscillator 0–100 | 62.9 | 60.2 | 69.8 | 56.2 | 28.0 |
| Avg Volume (50D)Average daily shares traded | 347K | 2.6M | 2.4M | 3.4M | 332K |
Analyst Outlook
Evenly matched — AAT and EQR each lead in 1 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: AAT as "Buy", WELL as "Buy", EQR as "Hold", VTR as "Buy", NHI as "Hold". Consensus price targets imply 13.8% upside for NHI (target: $85) vs -12.4% for AAT (target: $19). For income investors, AAT offers the higher dividend yield at 6.50% vs WELL's 1.30%.
| Metric | |||||
|---|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | Buy | Hold | Buy | Hold |
| Price TargetConsensus 12-month target | $18.50 | $233.25 | $70.61 | $93.91 | $85.40 |
| # AnalystsCovering analysts | 11 | 34 | 46 | 32 | 18 |
| Dividend YieldAnnual dividend ÷ price | +6.5% | +1.3% | +4.1% | +2.1% | +4.8% |
| Dividend StreakConsecutive years of raises | 5 | 2 | 8 | 1 | 1 |
| Dividend / ShareAnnual DPS | $1.37 | $2.76 | $2.69 | $1.86 | $3.61 |
| Buyback YieldShare repurchases ÷ mkt cap | +0.2% | 0.0% | +1.1% | 0.0% | 0.0% |
NHI leads in 2 of 6 categories (Income & Cash Flow, Profitability & Efficiency). AAT leads in 1 (Valuation Metrics). 2 tied.
AAT vs WELL vs EQR vs VTR vs NHI: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is AAT or WELL or EQR or VTR or NHI a better buy right now?
For growth investors, Welltower Inc.
(WELL) is the stronger pick with 35. 8% revenue growth year-over-year, versus -4. 7% for American Assets Trust, Inc. (AAT). Equity Residential (EQR) offers the better valuation at 22. 6x trailing P/E (47. 7x forward), making it the more compelling value choice. Analysts rate American Assets Trust, Inc. (AAT) a "Buy" — based on 11 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — AAT or WELL or EQR or VTR or NHI?
On trailing P/E, Equity Residential (EQR) is the cheapest at 22.
6x versus Ventas, Inc. at 160. 3x. On forward P/E, National Health Investors, Inc. is actually cheaper at 22. 2x — notably different from the trailing picture, reflecting expected earnings growth. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: American Assets Trust, Inc. wins at 3. 08x versus Equity Residential's 9. 36x.
03Which is the better long-term investment — AAT or WELL or EQR or VTR or NHI?
Over the past 5 years, Welltower Inc.
(WELL) delivered a total return of +202. 3%, compared to -21. 6% for American Assets Trust, Inc. (AAT). Over 10 years, the gap is even starker: WELL returned +225. 2% versus AAT's -22. 1%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — AAT or WELL or EQR or VTR or NHI?
By beta (market sensitivity over 5 years), National Health Investors, Inc.
(NHI) is the lower-risk stock at -0. 09β versus American Assets Trust, Inc. 's 0. 64β — meaning AAT is approximately -815% more volatile than NHI relative to the S&P 500. On balance sheet safety, Welltower Inc. (WELL) carries a lower debt/equity ratio of 49% versus 156% for American Assets Trust, Inc. — giving it more financial flexibility in a downturn.
05Which is growing faster — AAT or WELL or EQR or VTR or NHI?
By revenue growth (latest reported year), Welltower Inc.
(WELL) is pulling ahead at 35. 8% versus -4. 7% for American Assets Trust, Inc. (AAT). On earnings-per-share growth, the picture is similar: Ventas, Inc. grew EPS 184. 2% year-over-year, compared to -11. 5% for Welltower Inc.. Over a 3-year CAGR, WELL leads at 22. 7% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — AAT or WELL or EQR or VTR or NHI?
National Health Investors, Inc.
(NHI) is the more profitable company, earning 37. 6% net margin versus 4. 3% for Ventas, Inc. — meaning it keeps 37. 6% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: NHI leads at 51. 5% versus 3. 3% for WELL. At the gross margin level — before operating expenses — AAT leads at 61. 1%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is AAT or WELL or EQR or VTR or NHI more undervalued right now?
The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.
By this metric, American Assets Trust, Inc. (AAT) is the more undervalued stock at a PEG of 3. 08x versus Equity Residential's 9. 36x. Both stocks trade at elevated growth-adjusted valuations, so expected growth needs to materialise. On forward earnings alone, National Health Investors, Inc. (NHI) trades at 22. 2x forward P/E versus 119. 0x for Ventas, Inc. — 96. 9x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for NHI: 13. 8% to $85. 40.
08Which pays a better dividend — AAT or WELL or EQR or VTR or NHI?
All stocks in this comparison pay dividends.
American Assets Trust, Inc. (AAT) offers the highest yield at 6. 5%, versus 1. 3% for Welltower Inc. (WELL).
09Is AAT or WELL or EQR or VTR or NHI better for a retirement portfolio?
For long-horizon retirement investors, National Health Investors, Inc.
(NHI) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β -0. 09), 4. 8% yield). Both have compounded well over 10 years (NHI: +59. 2%, AAT: -22. 1%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between AAT and WELL and EQR and VTR and NHI?
Both stocks operate in the Real Estate sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
In terms of investment character: AAT is a small-cap income-oriented stock; WELL is a mid-cap high-growth stock; EQR is a mid-cap income-oriented stock; VTR is a mid-cap high-growth stock; NHI is a small-cap income-oriented stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.